Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1175175 (
SARS
)
19,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Severe acute respiratory syndrome
(
SARS
) has become a global public health emergency. Understanding the molecular mechanisms of
SARS
-induced cytopathic effects (CPEs) is a rational approach for the prevention of
SARS
, and an understanding of the cellular stress responses induced by viral infection is important for understanding the CPEs. Polyclonal antibodies, which recognized nucleocapsid (N) and membrane (M) proteins, detected viral N and M proteins in virus-infected Vero E6 cells at least 6 and 12 h post-infection (h.p.i.), respectively. Furthermore, detection of DNA ladder and cleaved caspase-3 in the virus-infected cells at 24h.p.i. indicated that
SARS-CoV infection
induced apoptotic cell death. Phosphorylation of p38 MAPK was significantly up-regulated at 18 h.p.i. in
SARS
-CoV-infected cells. The downstream targets of p38 MAPK,
MAPKAPK-2
, HSP-27, CREB, and eIF4E were phosphorylated in virus-infected cells. The p38 MAPK inhibitor, SB203580, inhibited effectively phosphorylation of HSP-27, CREB, and eIF4E in
SARS
-CoV-infected cells. However, viral protein synthesis was not affected by treatment of SB203580.
...
PMID:Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. 1519 98